Proliferation and enrichment of CD133+ glioblastoma cancer stem cells on 3D chitosan-alginate scaffolds

Biomaterials

Volumn 35, Issue 33, 2014, Pages 9137-9143

  Kievit, Forrest M ^a   Florczyk, Stephen J ^b,f   Leung, Matthew C ^b   Wang, Kui ^b   Wu, Jennifer D ^a,c   Silber, John R ^a   Ellenbogen, Richard G ^a   Lee, Jerry S H ^d,e   Zhang, Miqin ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b University of Washington   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d Whiting School of Engineering   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY   (United States)

Author keywords

Brain tumor initiating cells; Epithelial to mesenchymal transition; Hyaluronic acid; Microenvironment

Indexed keywords

BEHAVIORAL RESEARCH; CELL CULTURE; CHITOSAN; DISEASES; GENE EXPRESSION; HYALURONIC ACID; ONCOLOGY; STEM CELLS;

ANTI-CANCER THERAPIES; BRAIN TUMORS; CANCER STEM CELLS; CHITOSAN ALGINATES; DRUG DEVELOPMENT; EPITHELIAL-TO-MESENCHYMAL TRANSITION; INEXPENSIVE MEANS; MICROENVIRONMENTS;

SCAFFOLDS (BIOLOGY);

ALGINIC ACID; CD133 ANTIGEN; CHITOSAN; ANTINEOPLASTIC AGENT; GLUCURONIC ACID; HEXURONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER STEM CELL; CARCINOGENESIS; CARCINOGENICITY; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; ENRICHMENT CULTURE; EPITHELIAL MESENCHYMAL TRANSITION; GENE INDUCTION; GLIOBLASTOMA CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; MONOLAYER CULTURE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; TUMOR MICROENVIRONMENT; TUMOR XENOGRAFT; ANIMAL; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; DRUG SCREENING; GLIOBLASTOMA; SCANNING ELECTRON MICROSCOPY; TISSUE SCAFFOLD; TUMOR CELL LINE;

MUS MUSCULUS;

ALGINATES; ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; CHITOSAN; EPITHELIAL-MESENCHYMAL TRANSITION; GLIOBLASTOMA; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; MICE; MICE, NUDE; MICROSCOPY, ELECTRON, SCANNING; NEOPLASTIC STEM CELLS; TISSUE SCAFFOLDS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84906782568     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.07.037     Document Type: Article

References (33)

1. O'Brien C.A., Kreso A., Jamieson C.H. Cancer stem cells and self-renewal. Clin Cancer Res 2010, 16:3113-3120.
2. Rosen J.M., Jordan C.T. The increasing complexity of the cancer stem cell paradigm. Science 2009, 324:1670-1673.
3. Visvader J.E., Lindeman G.J. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 2008, 8:755-768.
4. Zhou B.B.S., Zhang H.Y., Damelin M., Geles K.G., Grindley J.C., Dirks P.B. Tumour-initiating cells: challenges and opportunities for anticancer drug discovery. Nat Rev Drug Discov 2009, 8:806-823.
5. Chen J., Li Y., Yu T.S., McKay R.M., Burns D.K., Kernie S.G., et al. Arestricted cell population propagates glioblastoma growth after chemotherapy. Nature 2012, 488:522-526.
6. Kelly S.E., Di Benedetto A., Greco A., Howard C.M., Sollars V.E., Primerano D.A., et al. Rapid selection and proliferation of CD133+ cells from cancer cell lines: chemotherapeutic implications. PLoS One 2010, 5:e10035.
7. Fischbach C., Chen R., Matsumoto T., Schmelzle T., Brugge J.S., Polverini P.J., et al. Engineering tumors with 3D scaffolds. Nat Methods 2007, 4:855-860.
8. Rao W., Zhao S., Yu J., Lu X., Zynger D.L., He X. Enhanced enrichment of prostate cancer stem-like cells with miniaturized 3D culture in liquid core-hydrogel shell microcapsules. Biomaterials 2014, 35:7762-7773.
9. Smith B.H., Gazda L.S., Conn B.L., Jain K., Asina S., Levine D.M., et al. Three-dimensional culture of mouse renal carcinoma cells in agarose macrobeads selects for a subpopulation of cells with cancer stem cell or cancer progenitor properties. Cancer Res 2011, 71:716-724.
10. Kievit F.M., Florczyk S.J., Leung M.C., Veiseh O., Park J.O., Disis M.L., et al. Chitosan-alginate 3D scaffolds as a mimic of the glioma tumor microenvironment. Biomaterials 2010, 31:5903-5910.
11. Leung M., Kievit F.M., Florczyk S.J., Veiseh O., Wu J., Park J.O., et al. Chitosan-alginate scaffold culture system for hepatocellular carcinoma increases malignancy and drug resistance. Pharm Res 2010, 27:1939-1948.
12. Borovski T., De Sousa E.M.F., Vermeulen L., Medema J.P. Cancer stem cell niche: the place to be. Cancer Res 2011, 71:634-639.
13. Li Z., Leung M., Hopper R., Ellenbogen R., Zhang M. Feeder-free self-renewal of human embryonic stem cells in 3D porous natural polymer scaffolds. Biomaterials 2010, 31:404-412.
14. Florczyk S.J., Kim D.J., Wood D.L., Zhang M. Influence of processing parameters on pore structure of 3D porous chitosan-alginate polyelectrolyte complex scaffolds. JBiomed Mater Res A 2011, 98:614-620.
15. Ricci-Vitiani L., Pallini R., Biffoni M., Todaro M., Invernici G., Cenci T., et al. Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature 2010, 468:824-828.
16. Fan X., Khaki L., Zhu T.S., Soules M.E., Talsma C.E., Gul N., et al. NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts. Stem Cells 2010, 28:5-16.
17. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., et al. Identification of human brain tumour initiating cells. Nature 2004, 432:396-401.
18. Westphal M., Lamszus K. The neurobiology of gliomas: from cell biology to the development of therapeutic approaches. Nat Rev Neurosci 2011, 12:495-508.
19. Jin X., Jeon H.Y., Joo K.M., Kim J.K., Jin J., Kim S.H., et al. Frizzled 4 regulates stemness and invasiveness of migrating glioma cells established by serial intracranial transplantation. Cancer Res 2011, 71:3066-3075.
20. Clement V., Sanchez P., de Tribolet N., Radovanovic I., Ruiz i Altaba A. HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr Biol 2007, 17:165-172.
21. Rizzo P., Miao H., D'Souza G., Osipo C., Song L.L., Yun J., et al. Cross-talk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches. Cancer Res 2008, 68:5226-5235.
22. Ikushima H., Todo T., Ino Y., Takahashi M., Miyazawa K., Miyazono K. Autocrine TGF-beta signaling maintains tumorigenicity of glioma-initiating cells through Sry-related HMG-box factors. Cell Stem Cell 2009, 5:504-514.
23. Lathia J.D., Gallagher J., Myers J.T., Li M., Vasanji A., McLendon R.E., et al. Direct invivo evidence for tumor propagation by glioblastoma cancer stem cells. PLoS One 2011, 6:e24807.
24. Mani S.A., Guo W., Liao M.J., Eaton E.N., Ayyanan A., Zhou A.Y., et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133:704-715.
25. Ouyang G., Wang Z., Fang X., Liu J., Yang C.J. Molecular signaling of the epithelial to mesenchymal transition in generating and maintaining cancer stem cells. Cell Mol Life Sci 2010, 67:2605-2618.
26. Misra S., Heldin P., Hascall V.C., Karamanos N.K., Skandalis S.S., Markwald R.R., et al. Hyaluronan-CD44 interactions as potential targets for cancer therapy. Febs J 2011, 278:1429-1443.
27. Toole B.P. Hyaluronan-CD44 interactions in cancer: paradoxes and possibilities. Clin Cancer Res 2009, 15:7462-7468.
28. Pattabiraman D.R., Weinberg R.A. Tackling the cancer stem cells - what challenges do they pose?. Nat Rev Drug Discov 2014, 13:497-512.
29. Chaffer C.L., Brueckmann I., Scheel C., Kaestli A.J., Wiggins P.A., Rodrigues L.O., et al. Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proc Natl Acad Sci U S A 2011, 108:7950-7955.
30. Gupta P.B., Fillmore C.M., Jiang G., Shapira S.D., Tao K., Kuperwasser C., et al. Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell 2011, 146:633-644.
31. Florczyk S.J., Liu G., Kievit F.M., Lewis A.M., Wu J.D., Zhang M. 3D porous chitosan-alginate scaffolds: a new matrix for studying prostate cancer cell-lymphocyte interactions invitro. Adv Healthc Mater 2012, 1:590-599.
32. Phan-Lai V., Kievit F.M., Florczyk S.J., Wang K., Disis M.L., Zhang M. CCL21 and IFNgamma recruit and activate tumor specific T cells in 3D scaffold model of breast cancer. Anticancer Agents Med Chem 2014, 14:204-210.
33. Phan-Lai V., Florczyk S.J., Kievit F.M., Wang K., Gad E., Disis M.L., et al. Three-dimensional scaffolds to evaluate tumor associated fibroblast-mediated suppression of breast tumor specific T cells. Biomacromolecules 2013, 14:1330-1337.